ESR1 and breast cancer: Although TNBC is characterized by the lack of expression of ERα, PR and HER-2 overexpression, this breast cancer subtype is capable of expressing other receptors like the androgen receptor (AR) or the estrogen receptor β (ERβ) [8,15,16].